ARCHIVES

Breast Cancer Incidence Reduced 45% In Tamoxifen Arm Of BCPT; Trial Unblinded

This article is from The Cancer Letter archive.

Vol. 24 No. 14 | April 10, 1998

Download PDF Visit The Full Archive

Related Articles

Urologists support Approval Of Il-2 for Kidney Cancer

February 1, 1991

In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure

July 5, 1991

CLF Makes Appointments To Board; Stovall Wins Award.

April 20, 2001

Congress Close to Approving Appropriations for FY 1985

September 14, 1984

In Brief: Columbia University Double Lab Space; GM Cancer Awards to Suit, Folkman, Nurse

June 6, 1997

NCI-Approved Clinical Trials

June 25, 2004